Who has invested in Cortexyme?

Sequoia Capital, Pfizer are named among the investors backing Cortexyme.

Cortexyme Funding: $92M Raised, Series B (2019)

Cortexyme funding overview

Cortexyme is based in South San Francisco, California. Cortexyme has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2019. The round record for Cortexyme runs through 2019; nothing later has been disclosed. Investors on record include Sequoia Capital, Pfizer. 2 distinct backers are named across the disclosed rounds.

Cortexyme at a glance

Total raised: $92M
Latest round: Series B
Latest round date: October 2019
Headquarters: South San Francisco, California
Notable investors: Sequoia Capital, Pfizer

Frequently asked about Cortexyme funding

How much has Cortexyme raised?: Cortexyme has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Cortexyme?: Sequoia Capital, Pfizer are named among the investors backing Cortexyme.
What was the latest Cortexyme funding round?: The most recent disclosed round is a Series B, announced in October 2019.
Where is Cortexyme based?: Cortexyme is based in South San Francisco, California.
When did Cortexyme last raise?: The last disclosed Cortexyme round closed in October 2019 at Series B.

We update the Cortexyme record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South San Francisco and their backers are listed below.

Cortexyme Funding: $92M Raised, Series B (2019)

Cortexyme funding overview

Cortexyme at a glance

Frequently asked about Cortexyme funding

Companies related to Cortexyme (36)

Browse related funding lists (5)